A trial looking at a blood test to reduce the use of fungal medication for certain blood cancers (BioDriveAFS)

This trial is looking at blood tests to check for signs of a fungal infection before giving an anti fungal medication. It is comparing this to the usual way of having medication to prevent a fungal infection developing.

It is for people who are having high dose chemotherapy for one of the following types of blood cancer:

• acute myeloid leukaemia

• high risk myelodysplastic syndrome

• acute lymphoblastic leukaemia

• myeloproliferative neoplasms that have changed to acute myeloid leukaemia